3Suppliers
0Customers
1Debt Items
20Related Chains

BeyondSpring Inc. Suppliers

TickerNameConfidenceEvidence
ASYMCHEM-LABORATORIES ASYMCHEM-LABORATORIES 90% We outsource the production of the active pharmaceutical ingredient of Plinabulin to external service providers, Johnson Matthey Pharma Services (JMPS) and Asymchem Laboratories (Asymchem)
BASF-SE BASF-SE 90% We rely on BASF SE as the sole supplier of the stabilizing agent, Kolliphor HS15, used in Plinabulin’s current formulation
PHARMACEUTICS-INTERNATIONAL-INC PHARMACEUTICS-INTERNATIONAL-INC 90% and the production of the final drug formulation to Pharmaceutics International Inc. (Pii) and for contingency planning purposes, we have also established relationships with other contract manufactur…

BeyondSpring Inc. Customers

No clients on recordNo downstream customers found in our database for BeyondSpring Inc..

BeyondSpring Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
BYSI-DEBT Debt stack $246,000 90% Market cache reports total debt of $246,000.

BeyondSpring Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for BeyondSpring Inc..

BeyondSpring Inc. Ownership

HolderNameConfidenceEvidence
BYSI-OWNER-DECHENG-CAPITAL-LLC Decheng Capital LLC 90% 13F overlay lists Decheng Capital LLC as top holder; 23 tracked holders.

BeyondSpring Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
FDMT 4D Molecular Therapeutics, Inc. 100.00 2
IMNM Immunome, Inc. 100.00 2
ACIU AC Immune SA 100.00 2
ACRS Aclaris Therapeutics, Inc. 100.00 2
VNDA Vanda Pharmaceuticals Inc. 100.00 2
VEEV Veeva Systems Inc. 100.00 2
ALEC Alector, Inc. 100.00 2
DSGN Design Therapeutics, Inc. 100.00 2
AXSM Axsome Therapeutics, Inc. 100.00 2
EDSA Edesa Biotech, Inc. 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
CTNM Contineum Therapeutics, Inc. 100.00 2
FHTX Foghorn Therapeutics Inc. 100.00 2
CRIS Curis, Inc. 100.00 2
NVO Novo Nordisk A/S 100.00 2
DAWN Day One Biopharmaceuticals Inc 100.00 2
SDGR Schrödinger, Inc. 100.00 2
ALNY Alnylam Pharmaceuticals, Inc. 100.00 2
AKTS Aktis Oncology, Inc. 100.00 2
VIVS VivoSim Labs, Inc. 100.00 2